Edition:
United Kingdom

Ocular Therapeutix Inc (OCUL.OQ)

OCUL.OQ on NASDAQ Stock Exchange Global Market

6.45USD
21 Sep 2018
Change (% chg)

$0.02 (+0.31%)
Prev Close
$6.43
Open
$6.45
Day's High
$6.47
Day's Low
$6.36
Volume
334,325
Avg. Vol
92,137
52-wk High
$8.26
52-wk Low
$3.30

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.38 December 24 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 2
(2) OUTPERFORM 5 4 4 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.80 1.80 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.47 0.50 0.35 0.53
Quarter Ending Dec-18 5 0.44 0.50 0.35 0.53
Year Ending Dec-18 6 1.92 2.00 1.69 4.19
Year Ending Dec-19 6 21.57 30.43 7.13 45.47
Earnings (per share)
Quarter Ending Sep-18 5 -0.38 -0.35 -0.39 -0.46
Quarter Ending Dec-18 5 -0.38 -0.33 -0.44 -0.51
Year Ending Dec-18 6 -1.53 -1.43 -1.70 -1.82
Year Ending Dec-19 6 -1.37 -0.77 -1.73 -0.16

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.38 0.65 0.27 72.80
Quarter Ending Mar-18 0.45 0.34 0.11 24.75
Quarter Ending Dec-17 0.52 0.49 0.04 6.95
Quarter Ending Sep-17 0.51 0.52 0.01 2.35
Quarter Ending Jun-17 0.49 0.44 0.05 10.02

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.47 0.47 0.46 0.43 0.53
Quarter Ending Dec-18 0.44 0.44 0.43 0.45 0.53
Year Ending Dec-18 1.92 1.92 1.90 1.70 4.19
Year Ending Dec-19 21.57 21.57 22.25 26.62 45.47

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings